Endothelial dysfunction in a general practitioner’s work

Мұқаба

Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Тек жазылушылар үшін

Аннотация

Endothelial dysfunction (ED) is a pathological condition that is impairment in the synthesis of endothelial factors and is a major component in the pathogenesis of many diseases, including those of a therapeutic profile. Many specialists now consider ED as a universal component in the development of cardiovascular and respiratory diseases. The paper contains information about the main functions of the endothelium and their impact on the organs and systems of the body, the state of microhemocirculation, and the entire internal environment. It also considers ED that affects vasomotor, hemostatic, adhesive, and angiogenic functions and the main markers of endothelial damage. The possibilities of preventive measures and pharmacological correction of ED are discussed.

Толық мәтін

##article.viewOnOriginalSite##

Авторлар туралы

E. Svetlichnaya

Volgograd State Medical University, Ministry of Health of Russia

Хат алмасуға жауапты Автор.
Email: vskvortsov1@ya.ru
Ресей, Volgograd

V. Skvortsov

Volgograd State Medical University, Ministry of Health of Russia

Email: vskvortsov1@ya.ru

Professor, MD

Ресей, Volgograd

B. Levitan

Astrakhan State Medical University, Ministry of Health of Russia

Email: vskvortsov1@ya.ru

Professor, MD

Ресей, Astrakhan

I. Rodionova

Volgograd State Medical University, Ministry of Health of Russia

Email: vskvortsov1@ya.ru

Associate Professor, Candidate of Medical Sciences

Ресей, Volgograd

D. Shtonda

Volgograd State Medical University, Ministry of Health of Russia

Email: vskvortsov1@ya.ru
Ресей, Volgograd

Әдебиет тізімі

  1. Stepanova T.V., Ivanov A.N., Popykhova E.B. et al. Endotelial'naya disfunktsiya i ee markery. Evraziiskoe nauchnoe ob"edinenie. 2018; 11-2: 120–3 (in Russ.).
  2. Sevket B. Endothelial Dysfunction and Inflammatory Markers of Vascular Disease. Curr Vasc Pharmacol. 2021; 19 (3): 243–9. doi: 10.2174/1570161118666200421142542
  3. Dildar K., Hafize U. Endothelial Dysfunction and Hypertension. Adv Exp Med Biol. 2017; 956: 511–40. doi: 10.1007/5584_2016_90
  4. Vasina L.V., Petrishchev N.N., Vlasov T.D. Markers of endothelial dysfunction. Regional blood circulation and microcirculation. 2017; 16 (1): 4–15 (in Russ.). doi: 10.24884/1682-6655-2017-16-1-4-15
  5. Gozhenko A.I., Kuznetsova H.S., Kuznetsova K.S. et al. Endothelial dysfunction in the pathogenesis of diabetes complications The message I. Endothelial dysfunction: etiology, pathogenesis and diagnostic methods Endokrynologia. 2017; 22 (2): 171–81 (in Russ.).
  6. Petrishchev N.N., Vasina L.V., Vlasov T.D. et al. Tipovye formy disfunktsii endoteliya. Kliniko-laboratornyi konsilium. 2007; 18: 31–5 (in Russ.).
  7. Ryabchenko А.Yu., Dolgov А.М., Denisov Е.N. et al. Role of nitric oxide and endothelin-1 in the development of ischemic disorders of cerebral circulation. Neurology Bulletin. 2014; 1: 34–7 (in Russ.).
  8. Pavlovic R.F., Kocic G., Simonovic D. et al. Effects of Music Therapy on Endothelial Function in Patients With Coronary Artery Disease Participating in Aerobic Exercise Therapy. Altern Ther Health Med. 2017; 23 (3): at5491.
  9. Shishkin A.N., Lyndina M.L. Endothelial dysfunction and hypertension. Arterial’naya Gipertenziya = Arterial Hypertension. 2008; 14 (4): 315–9 (in Russ.). doi: 10.18705/1607-419X-2008-14-4-315-319
  10. Terentieva N.N., Popova M.A. Assessment of endothelial dysfunction with combination of ischemic heart disease and chronic obstructive pulmonary disease. Vestnik SurGU. 2015; 2 (24): 36–9 (in Russ.).
  11. Samoluk M.O., Grigorieva N.Yu. Current understanding of endothelial dysfunction in patients presenting comorbid cardiopulmonary pathology (review). Meditsinskii al'manakh. 2020; 1: 27–9 (in Russ.).
  12. Shurygin M.G., Shurygina I.A., Kanya O.V. et al. Ignificance of the increased production of endothelin in myocardial infarction. Fundamental Research. 2015; 1: 1281–7 (in Russ.).
  13. Chernova E.V. Von Willebrand factor. Herald of North-Western State Medical University named after I.I. Mechnikov. 2018; 10 (4): 73–80 (in Russ.). doi: 10.17816/mechnikov201810473-80
  14. Sokolov E.I., Grishina T.I., Shtin S.R. Effect of von Willebrand factor and endothelin-1 on formation of thrombotic status in patients with ischemic heart disease. Kardiologiya. 2013; 3: 25–30 (in Russ.).
  15. Vlasov T.D., Nesterovich I.I., Shimanski D.A. Endothelial dysfunction: from the particular to the general. Return to the «Old Paradigm»? Regional blood circulation and microcirculation. 2019; 18 (2): 19–27 (in Russ.). doi: 10.24884/1682-6655-2019-18-2-19-27
  16. Olson N.E., Chao S., Lindner V. et al. Intimal smooth muscle cell proliferation after balloon catheter injury: the role of basic fibroblast growth factor. Am J Pathol. 1992; 140: 1017–23.
  17. Shvangiradze T.A., Bondarenko I.Z., Troshina E.A. et al. Angiotensin II and transforming growth factor β affect cardiovascular and renal disease in patients with type 2 diabetes mellitus: benefits of dpp-4 inhibitors treatment. Obesity and metabolism. 2019; 16 (3): 55–61 (in Russ.). doi: 10.14341/omet10346
  18. Vorobyeva E.N., Vorobуev R.I., Sharlaeva E.A. et al. Endothelial dysfunction in cardiovascular diseases: risk factors, methods of diagnostic, and correction. Acta Biologica Sibirica. 2016; 1: 21–40 (in Russ.). doi: 10.14258/abs.v2i1.1219
  19. Dedov D.V., Mazaev V.P., Ryazanova S.V. et al. Predictors of cardiovascular complications in men with stable coronary heart disease and arterial hypertension. Modern problems of science and education. 2020; 5: 124 (in Russ.). doi: 10.17513/spno.30195

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>